New antiplatelet agents in ACS - Part II

Session comprising selected EuroPCR 2014 abstract submissions

Chairpersons: A. Gershlick, J. Silvain

Presentations available when logged in:

  • Impact of platelet volume and platelet reactivity on thrombotic events in ACS patients on clopidogrel or prasugrel after PCI
  • Effectiveness of switching Prasugrel's 'low responders' to Ticagrelor after ACS
  • Comparison of double (360 mg) Ticagrelor loading dose with standard (60 mg) Prasugrel loading dose in STEMI patients: the rapid activity of platele...
  • Clinical outcome after PCI and ticagrelor or clopidogrel in patients with ACS in a real world setting
  • Benefits from new adenosine-diphosphate antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome: a meta-an...